Variant report
Variant | nsv819299 |
---|---|
Chromosome Location | chr13:29752285-29754724 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:29754593..29756935-chr13:29798508..29800857,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550401940 | chr13:29752334-29752335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4769684 | chr13:29752354-29752355 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs149975468 | chr13:29752401-29752402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17072887 | chr13:29752441-29752442 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs11840899 | chr13:29752452-29752453 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs200127056 | chr13:29752462-29752463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17072891 | chr13:29752497-29752498 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs568272609 | chr13:29752524-29752525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76278067 | chr13:29752548-29752549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183184729 | chr13:29752583-29752584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550499941 | chr13:29752588-29752589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149206641 | chr13:29752638-29752639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539003045 | chr13:29752641-29752642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375396381 | chr13:29752642-29752643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188722357 | chr13:29752646-29752647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369165144 | chr13:29752680-29752681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566413418 | chr13:29752717-29752718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35251425 | chr13:29752739-29752740 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs554843353 | chr13:29752751-29752752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11361210 | chr13:29752781-29752782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575023400 | chr13:29752806-29752807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192426177 | chr13:29752830-29752831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7329581 | chr13:29752831-29752832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557648530 | chr13:29752832-29752833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565827555 | chr13:29752995-29752996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552957878 | chr13:29753013-29753014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534756770 | chr13:29753038-29753039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs9508305 | chr13:29753054-29753055 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs542353472 | chr13:29753076-29753077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557151410 | chr13:29753089-29753090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542353346 | chr13:29753118-29753119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561721835 | chr13:29753137-29753138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9508306 | chr13:29753146-29753147 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs546105409 | chr13:29753150-29753151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377000766 | chr13:29753193-29753194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142456704 | chr13:29753216-29753217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570386545 | chr13:29753231-29753232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570370346 | chr13:29753234-29753235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533075713 | chr13:29753242-29753243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9508307 | chr13:29753269-29753270 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs369509835 | chr13:29753272-29753273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9508308 | chr13:29753278-29753279 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs7335449 | chr13:29753300-29753301 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs140656741 | chr13:29753403-29753404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183959551 | chr13:29753424-29753425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9579301 | chr13:29753427-29753428 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs115416210 | chr13:29753524-29753525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145827978 | chr13:29753550-29753551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540164714 | chr13:29753577-29753578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553397536 | chr13:29753595-29753596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Malignant glioma | 17146433 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Peters Plus syndrome | 16909395 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Breast cancer | 20031965 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Ovarian cancer | 19047089 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:29734400-29752600 | Weak transcription | Aorta | Aorta |
2 | chr13:29745600-29752400 | Weak transcription | Fetal Heart | heart |
3 | chr13:29752400-29753200 | Enhancers | Fetal Heart | heart |
4 | chr13:29752600-29752800 | Enhancers | Aorta | Aorta |
5 | chr13:29753200-29765000 | Weak transcription | Fetal Heart | heart |